Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Anna C, Simcocks"'
Autor:
Anna C Simcocks, Kayte A Jenkin, Lannie O’Keefe, Chrishan S Samuel, Michael L Mathai, Andrew J McAinch, Deanne H Hryciw
Publikováno v:
Endocrine Connections, Vol 8, Iss 3, Pp 203-216 (2019)
Atypical cannabinoid compounds O-1602 and O-1918 are ligands for the putative cannabinoid receptors G protein-coupled receptor 55 and G protein-coupled receptor 18. The role of O-1602 and O-1918 in attenuating obesity and obesity-related pathologies
Externí odkaz:
https://doaj.org/article/ccc1aef53ea04ec6a00a6e7a1e01c9c8
Publikováno v:
Journal of Functional Foods, Vol 51, Iss , Pp 55-64 (2018)
Incidence of type II diabetes mellitus (T2DM) is rapidly increasing worldwide. This study aimed to investigate whether cyanidin-3-O-β-glucoside (C3G), or peptides with angiotensin converting enzyme (ACE) inhibitory activity, alone or in combination,
Externí odkaz:
https://doaj.org/article/8472513f43f24cf2a36d0b3b6344bbdb
Autor:
Lannie, O'Keefe, Teresa, Vu, Anna C, Simcocks, Kayte A, Jenkin, Michael L, Mathai, Deanne H, Hryciw, Dana S, Hutchinson, Andrew J, McAinch
Publikováno v:
International journal of molecular sciences. 23(19)
Diet-induced obesity (DIO) reduces fatty acid oxidation in skeletal muscle and decreases circulating levels of adiponectin. Endocannabinoid signaling is overactive in obesity, with some effects abated by antagonism of cannabinoid receptor 1 (CB
Autor:
Lannie O’Keefe, Teresa Vu, Anna C. Simcocks, Kayte A. Jenkin, Michael L. Mathai, Andrew J. McAinch, Dana S. Hutchinson, Deanne H. Hryciw
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 8; Pages: 7601
Diet-induced obesity (DIO) is a contributor to co-morbidities, resulting in alterations in hormones, lipids, and low-grade inflammation, with the cannabinoid type 2 receptor (CB2) contributing to the inflammatory response. The effects of modulating C
Autor:
Andrew J. McAinch, Chrishan S. Samuel, Michael L. Mathai, Deanne H. Hryciw, Anna C. Simcocks, Kayte A. Jenkin, Lannie O'Keefe
Publikováno v:
Endocrine Connections, Vol 8, Iss 3, Pp 203-216 (2019)
Endocrine Connections
Endocrine Connections
Atypical cannabinoid compounds O-1602 and O-1918 are ligands for the putative cannabinoid receptors G protein-coupled receptor 55 and G protein-coupled receptor 18. The role of O-1602 and O-1918 in attenuating obesity and obesity-related pathologies
Autor:
Lannie O'Keefe, Teresa Vu, Anna C. Simcocks, Kayte A. Jenkin, Michael L. Mathai, Deanne H. Hryciw, Dana S. Hutchinson, Andrew J. McAinch
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 19; Pages: 11447
Diet-induced obesity (DIO) reduces fatty acid oxidation in skeletal muscle and decreases circulating levels of adiponectin. Endocannabinoid signaling is overactive in obesity, with some effects abated by antagonism of cannabinoid receptor 1 (CB1). Th
Publikováno v:
Journal of Functional Foods, Vol 51, Iss, Pp 55-64 (2018)
Incidence of type II diabetes mellitus (T2DM) is rapidly increasing worldwide. This study aimed to investigate whether cyanidin-3-O-β-glucoside (C3G), or peptides with angiotensin converting enzyme (ACE) inhibitory activity, alone or in combination,
Autor:
Lannie O'Keefe, Kayte A. Jenkin, Andrew J. McAinch, Esther Grinfeld, Michael L. Mathai, Deanne H. Hryciw, Lauren M Cornall, Anna C. Simcocks
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 21, Iss 5922, p 5922 (2020)
Volume 21
Issue 16
International Journal of Molecular Sciences, Vol 21, Iss 5922, p 5922 (2020)
Volume 21
Issue 16
O-1602 and O-1918 are atypical cannabinoid ligands for GPR55 and GPR18, which may be novel pharmaceuticals for the treatment of obesity by targeting energy homeostasis regulation in skeletal muscle. This study aimed to determine the effect of O-1602
Autor:
Gayathri Rajaraman, Dana S. Hutchinson, Anna C. Simcocks, Deanne H. Hryciw, Andrew J. McAinch
Publikováno v:
Molecular Nutrition & Food Research. 60:92-102
Endocannabinoids are products of dietary fatty acids that are modulated by an alteration in food intake levels. Overweight and obese individuals have substantially higher circulating levels of the arachidonic acid derived endocannabinoids, anandamide
Autor:
Lannie O'Keefe, Anna C. Simcocks, Michael L. Mathai, Esther Grinfeld, Kayte A. Jenkin, Deanne H. Hryciw, Andrew J. McAinch
Publikováno v:
Journal of Endocrinology. 225:113-124
Modulation of the endocannabinoid system as an anti-obesity therapeutic is well established; however, the direct effects of cannabinoid receptor 1 (CB1) antagonism on renal function and structure in a model of diet-induced obesity (DIO) are unknown.